Form 8-K ANTARES PHARMA, INC. For: Aug 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Antares Pharma's (ATRS) CFO Resigns
August 11, 2016 7:15 AM EDTAntares Pharma (NASDAQ: ATRS) disclosed in an SEC filing:
On August 5, 2016, Antares Pharma, Inc. (the Company) received a written notice of resignation from James E. Fickenscher, the Companys Senior Vice President and Chief Financial Officer. Mr. Fickenschers resignation will become effective September 4, 2016.... More
